Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Senhwa Biosciences Inc (6492) Financial Statements

Senhwa Biosciences Inc Financial Overview

Senhwa Biosciences Inc's market cap is currently NT$3.44B. The company's EPS TTM is NT$-3.29; its P/E ratio is -9.10; Senhwa Biosciences Inc has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 1.07MNT$ 1.00MNT$ 1.00MNT$ 1.00MNT$ 550.00K
Gross ProfitNT$ 520.00KNT$ 477.00KNT$ 552.00KNT$ -6.61MNT$ -5.91M
Operating IncomeNT$ -278.26MNT$ -306.19MNT$ -311.11MNT$ -356.12MNT$ -346.32M
EBITDANT$ -266.15MNT$ -279.71MNT$ -283.79MNT$ -340.60MNT$ -321.59M
Net IncomeNT$ -264.77MNT$ -293.75MNT$ -296.31MNT$ -349.63MNT$ -329.26M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 771.78MNT$ 1.03BNT$ 1.32BNT$ 1.62BNT$ 2.03B
Total AssetsNT$ 819.26MNT$ 1.07BNT$ 1.36BNT$ 1.65BNT$ 2.06B
Total DebtNT$ 22.12MNT$ 14.99MNT$ 9.60MNT$ 16.16MNT$ 15.38M
Net DebtNT$ -749.67MNT$ -1.01BNT$ -1.31BNT$ -1.60BNT$ -2.02B
Total LiabilitiesNT$ 58.30MNT$ 38.92MNT$ 46.17MNT$ 40.93MNT$ 92.44M
Stockholders' EquityNT$ 760.96MNT$ 1.03BNT$ 1.32BNT$ 1.61BNT$ 1.97B
Cash Flow
Free Cash FlowNT$ -248.74MNT$ -296.17MNT$ -291.13MNT$ -400.34MNT$ -300.45M
Operating Cash FlowNT$ -248.46MNT$ -294.22MNT$ -286.35MNT$ -399.97MNT$ -300.05M
Investing Cash FlowNT$ 5.82MNT$ 6.71MNT$ -5.26MNT$ -590.00KNT$ 149.00K
Financing Cash FlowNT$ -9.34MNT$ -8.72MNT$ -8.83MNT$ -19.55MNT$ -34.24M

Currency in TWD

Senhwa Biosciences Inc Earnings and Revenue History

-500M-250M0250M-150000 %-100000 %-50000 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Senhwa Biosciences Inc Liabilities to Assets

01B2B3B2 %4 %6 %8 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Senhwa Biosciences Inc Cash Flow

-1B-500M0500M1B1.5B2B201720182019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Senhwa Biosciences Inc Forecast EPS vs Actual EPS

-1-0.9-0.8-0.7-0.6-0.5Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26EPS EstimateBeatMiss
Earnings >